Clinical Trials Browser

Phase EARLY_PHASE1 × Carcinoma, Renal Cell × pembrolizumab × Clear all

NCT05733715 2025-03-03

Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

Phase EARLY_PHASE1 Recruiting

Carcinoma, Renal Cell